JPY 1196.0
(0.34%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -8.05 Billion | 4.47 Billion | 9.28 Billion | 8.17 Billion | 1.8 Billion | 112 Million |
Net Income | 4.64 Billion | 6.6 Billion | 6.99 Billion | -1.52 Billion | -21.17 Billion | 2.45 Billion |
Depreciation & Amortization | 2.54 Billion | 2.44 Billion | 2.37 Billion | 2.18 Billion | 2.89 Billion | 2.16 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -14.51 Billion | -3.11 Billion | 4.57 Billion | 7.57 Billion | 1.24 Billion | -4.68 Billion |
Other non-cash items | 19.52 Billion | -1.45 Billion | -4.65 Billion | -71 Million | 18.84 Billion | 176 Million |
Investing Cash Flow | 483 Million | -526 Million | -1.37 Billion | -2.22 Billion | -3.56 Billion | -449 Million |
Investments in PPE | -1.55 Billion | -1.71 Billion | -1.92 Billion | -1.13 Billion | -1.06 Billion | -1.12 Billion |
Acquisitions | 225 Million | 29 Million | 4.11 Billion | -2.06 Billion | -4.56 Billion | -544 Million |
Investment purchases | -1.62 Billion | -304 Million | -3.75 Billion | -200 Million | -337 Million | -410 Million |
Sales/Maturities of investments | 3.38 Billion | 1.45 Billion | 171 Million | 1.17 Billion | 2.34 Billion | 1.5 Billion |
Other Investing Activities | 46 Million | 11 Million | 12 Million | 5 Million | 44 Million | 125 Million |
Financing Cash Flow | -4.87 Billion | -4.07 Billion | -2.94 Billion | 9.28 Billion | -5.05 Billion | -12.78 Billion |
Debt repayment | -108 Million | -139 Million | -199 Million | -97 Million | - | -10 Billion |
Dividends payments | -2.43 Billion | -3.06 Billion | -1.4 Billion | -1.12 Billion | -2.28 Billion | -2.32 Billion |
Common Stock Repurchased | -1.5 Billion | -1 Million | -998 Million | - | -2.67 Billion | - |
Common Stock Issuance | - | -871 Million | -340 Million | - | - | - |
Other Financing Activities | -701 Million | -2 Million | -1 Million | 10.5 Billion | -96 Million | -460 Million |
Accounts receivables | -5.63 Billion | -3.15 Billion | 1.61 Billion | 3.42 Billion | 11.53 Billion | -828 Million |
Accounts payables | -6.76 Billion | 4.71 Billion | 2.95 Billion | -4.3 Billion | -3.95 Billion | 720 Million |
Inventory | -2.76 Billion | -4.16 Billion | 223 Million | 7.57 Billion | -4.4 Billion | -3.98 Billion |
Other working capital | 640 Million | -510 Million | -218 Million | 879 Million | -1.93 Billion | -590 Million |
Cash at beginning of period | 60.94 Billion | 60.32 Billion | 54.32 Billion | 38.58 Billion | 45.67 Billion | 58.82 Billion |
Cash at end of period | 39.78 Billion | 60.94 Billion | 60.32 Billion | 54.32 Billion | 38.58 Billion | 45.67 Billion |
Capital Expenditure | -1.55 Billion | -1.71 Billion | -1.92 Billion | -1.13 Billion | -1.06 Billion | -1.12 Billion |
Effect of forex changes on cash | 1.16 Billion | 751 Million | 1.03 Billion | 491 Million | -266 Million | -26 Million |
Net cash flow / Change in cash | -21.15 Billion | 624 Million | 6 Billion | 15.73 Billion | -7.08 Billion | -13.15 Billion |
Free Cash Flow | -9.6 Billion | 2.76 Billion | 7.35 Billion | 7.03 Billion | 745 Million | -1 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 621 Million | 4.64 Billion | 3.35 Billion | 143 Million | 1.12 Billion | 15 Million |
Depreciation & Amortization | - | 2.54 Billion | - | 645 Million | 638 Million | 604 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -14.51 Billion | - | - | - | - |
Other non-cash items | -621 Million | 19.52 Billion | -3.35 Billion | -143 Million | -1.12 Billion | -15 Million |
Investing Cash Flow | - | 483 Million | - | - | - | - |
Investments in PPE | - | -1.55 Billion | - | - | - | - |
Acquisitions | - | 225 Million | - | - | - | - |
Investment purchases | - | -1.62 Billion | - | - | - | - |
Sales/Maturities of investments | - | 3.38 Billion | - | - | - | - |
Other Investing Activities | - | 46 Million | - | - | - | - |
Financing Cash Flow | - | -4.87 Billion | - | - | - | - |
Debt repayment | - | -108 Million | - | - | - | - |
Dividends payments | - | -2.43 Billion | - | - | - | - |
Common Stock Repurchased | - | -1.5 Billion | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -701 Million | - | - | - | - |
Accounts receivables | - | -5.63 Billion | - | - | - | - |
Accounts payables | - | -6.76 Billion | - | - | - | - |
Inventory | - | -2.76 Billion | - | - | - | - |
Other working capital | - | 640 Million | - | - | - | - |
Cash at beginning of period | - | 60.94 Billion | - | 50.54 Billion | 41.78 Billion | 60.94 Billion |
Cash at end of period | - | 39.78 Billion | - | 34.42 Billion | 50.54 Billion | 41.78 Billion |
Capital Expenditure | - | -1.55 Billion | - | - | - | - |
Effect of forex changes on cash | - | 1.16 Billion | - | - | - | - |
Net cash flow / Change in cash | - | -21.15 Billion | - | -16.11 Billion | 8.75 Billion | -19.16 Billion |
Free Cash Flow | - | -9.6 Billion | - | 1.29 Billion | 1.27 Billion | 1.2 Billion |
JOHNPHARMA
GML
2125
ASMVF
MAHAPEXLTD
DRMA